|
|
||||||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Journal of Lipid Research, Vol. 45, 1674-1682, September 2004
Copyright © 2004 by American Society for Biochemistry and Molecular Biology

* Department of Biochemistry, University of Wisconsin, Madison, WI 53706
Department of Nutritional Sciences, University of Wisconsin, Madison, WI 53706
Published, JLR Papers in Press, June 21, 2004. DOI 10.1194/jlr.M400039-JLR200
1 To whom correspondence should be addressed. e-mail: ntambi{at}biochem.wisc.edu
| ABSTRACT |
|---|
|
|
|---|
coactivator-1
were increased in the SCD1/ mice. Both lipolysis and fatty acid oxidation were increased in the SCD1/ mice. When exposed to 4°C, SCD1/ mice showed hypothermia, hypoglycemia, and depleted liver glycogen. High levels of dietary oleate partially compensated for the hypothermia and rescued plasma glucose and liver glycogen. These results suggest that SCD1 deficiency stimulates basal thermogenesis through the upregulation of the ß3-AR-mediated pathway and a subsequent increase in lipolysis and fatty acid oxidation in BAT. The hypothermia and hypoglycemia in cold-exposed SCD1/ mice and the compensatory recovery by oleate indicate an important role of SCD1 gene expression in thermoregulation.
Abbreviations: ß3-AR, ß3-adrenergic receptor; BAT, brown adipose tissue; CREB, cAMP response element binding protein; DAG, diacylglycerol; HSL, hormone-sensitive lipase; PCA, perchloric acid; PGC1
, peroxisome proliferator-activated receptor-
coactivator-1
; PL, phospholipid; SCD, stearoyl-CoA desaturase; TG, triglyceride; UCP, uncoupling protein
Supplementary key words brown adipose tissue uncoupling protein lipid metabolism
| INTRODUCTION |
|---|
|
|
|---|
9 position of fatty acyl-CoA substrates. The major monounsaturated fatty acids of triglyceride (TG), cholesteryl esters, and membrane phospholipids are palmitoleic and oleic acids (1). The ratio of stearic acid to oleic acid is one of the factors influencing cell membrane fluidity, and an alteration in this ratio is implicated in obesity, aging, and various diseases such as diabetes, heart disease, and cancer (2). Four SCD isoforms exist in the mouse genome. SCD1 is expressed in liver and brown and white adipose tissue, whereas SCD2 is expressed in brain and brown and white adipose tissue (3). SCD3 is expressed mainly in the skin and Harderian gland (4), whereas SCD4 is expressed in heart (5). Recent studies of the asebia mouse strains (ab j and ab 2j) with a naturally occurring mutation in SCD1 and a laboratory mouse model with a targeted disruption (SCD1/) provide new insights into the physiological role of the SCD1 gene and its endogenous products (6, 7). Mice with a targeted disruption of the SCD1 gene had reduced adiposity. TG synthesis in liver was decreased relative to that in the wild type, which suggests that SCD1 gene expression is highly correlated with fat accumulation (7). The reduction in fat accumulation of SCD1/ mice was the result of downregulation in the expression of lipogenic genes (FAS, SREBP1, GPAT) and upregulation in the expression of genes involved in fatty acid oxidation (8). In addition, SCD1 deficiency decreased the obese phenotype of the ob/ob mouse (9), suggesting that obesity is highly correlated with SCD1 expression.
Energy expenditure is an important factor in the regulation of body weight. Heat production (thermogenesis) represents a major form of energy expenditure and plays a significant role in the maintenance of energy balance. Brown adipose tissue (BAT) is the primary site of thermogenesis and potentially functions to regulate body weight in rodents (10, 11). Therefore, enhanced function of BAT is a significant factor that increases energy expenditure and reduces obesity. Uncoupling protein 1 (UCP1) is predominantly expressed in BAT of rodents and functions to uncouple oxidative respiration from ATP synthesis, resulting in dissipation of energy as heat (12). The UCP1 gene in BAT is activated in response to cold exposure and plays a part in the maintenance of body temperature, as demonstrated in UCP1 knockout mice that showed cold sensitivity and lower oxygen consumption (13, 14). Two structurally homologous UCPs, UCP2 and UCP3, have been identified in BAT of rodents (15, 16); however, their role in nonshivering thermogenesis remains unclear (14).
Recently, there has been growing interest in the role of ß3-adrenergic receptor (ß3-AR) because of its predominant expression in adipose tissue and potential as a pharmacological target to control energy expenditure and lipid accretion (17). Pharmacological studies indicate that the ß-AR subtype responsible for the stimulation of oxygen consumption and UCP expression is exclusively the ß3 subtype (18). Stimulation of ß3-ARs leads to nonshivering thermogenesis via the activation of UCPs in brown fat (19). Activated ß3-AR is coupled to the adenylyl cyclase and stimulates subsequent catalytic responses through signal transduction via protein kinase A (19), which phosphorylates multiple targets, including cAMP response element binding protein (CREB) (20) and hormone-sensitive lipase (HSL) (21). On the other hand, it is believed that free fatty acids serve as substrates for mitochondrial oxidation and provide a signal to activate UCP1 (22). Fatty acids mimic the noradrenaline effects and stimulate UCP1 expression in cultured brown adipocytes, even though the physiological route is unknown (14, 23, 24).
In a previous study, we have shown that SCD1 knockout mice have enhanced oxygen consumption and metabolic rate (8). However, the physiological role and significance of SCD1 deficiency in thermoregulation has not been investigated. The objective of the current study was to examine whether deficiency of SCD1 induces the thermogenic activity of BAT. We found that SCD1 deficiency increased basal thermogenesis through the activation of a ß3-AR-mediated pathway and subsequent increases in lipolysis and fatty acid oxidation in BAT of mice. However, upon cold exposure, SCD1/ mice develop hypothermia, which is associated with hypoglycemia and depletion of liver glycogen. Dietary oleate partially compensates for hypothermia and hypoglycemia in cold-exposed SCD1/ mice, suggesting that endogenously synthesized oleate plays a role in the control of thermoregulation associated with glycogen and lipid metabolism.
| EXPERIMENTAL PROCEDURES |
|---|
|
|
|---|
Materials
Antibodies for UCP1 and phosphorylated CREB (pCREB) were purchased from Alpha Diagnostic (San Antonio, TX) and Cell Signaling (Beverly, MA), respectively. Antibodies for ß3-AR and peroxisome proliferator-activated receptor-
coactivator-1
(PGC1
) were purchased from Santa Cruz Biotechnology (Santa Cruz, CA).
-[32P]dCTP and L-[3H]carnitine were obtained from NEN Life Science (Boston, MA) and American Radiolabeled Chemicals (St. Louis, MO), respectively. TLC plates (TLC Silica Gel G60) were from Merck (Darmstadt, Germany). All chemicals were purchased from Sigma Chemical (St. Louis, MO) unless otherwise specified.
Isolation and analysis of RNA
Total RNA was isolated from BAT with Trizol Reagent (Invitrogen, Carlsbad, CA) according to the manufacturer's instructions. Twenty micrograms of total RNA was fractionated on 1.0% agarose-2.2 M formaldehyde gels and transferred to Hybond N+ nylon membrane. After ultraviolet cross-linking, the membrane was hybridized with cDNA probes labeled with [32P]dCTP by a random primer labeling kit (Promega, Madison, WI). After washing, the membranes were exposed to X-ray film at 80°C, and signals were quantified by densitometry on an ImageQuant densitometer (Molecular Dynamics, Sunnyvale, CA). The following previously described cDNAs were used for Northern analysis: UCP1 (26), UCP2 (26), and UCP3 (27). The probes for ß3-AR and HSL were prepared by RT-PCR using the following primers: for ß3-AR, forward (5'-AGGCAACCTGCTGGTAATCATAGC-3') and reverse (5'-ACAACGAACACTCGAGCATAGACG-3') (GenBank accession number NM_013462); for HSL, forward (5'-TTTTGACCTGGACACAGAGACACC-3') and reverse (5'-CTGTCTCGTTGCGTTTGTAGTGCT-3') (GenBank accession number NM_010719).
Western blotting
BAT was homogenized in ice-cold 50 mM HEPES buffer (pH 7.4) containing 150 mM NaCl, 10 mM sodium pyrophosphate, 2 mM Na3VO4, 10 mM NaF, 2 mM EDTA, 2 mM PMSF, 5 µg/ml leupeptin, 1% Nonidet P-40, and 10% glycerol and centrifuged at 12,000 rpm for 10 min at 4°C. The proteins were resolved by 12% SDS-PAGE, transferred to polyvinylidene difluoride membranes, and blotted by using antibodies for UCP1, ß3-AR, pCREB, and PGC1
. The proteins were visualized using the enhanced chemiluminescence detection system (Amersham Biosciences) as described by the manufacturer and quantified by densitometry.
Preparation of mitochondria and CPT1 activity assay
Mitochondria were isolated as previously described by Vance (28). Carnitine palmitoyltransferase 1 (CPT1) activity was measured as described by Brener (29). A total of 200 µg of mitochondrial protein was added to assay medium containing 20 mM HEPES, pH 7.3, 75 mM KCl, 2 mM KCN, 1% fat-free BSA, 70 µM palmitoyl-CoA, and 0.25 mM L-[3H]carnitine. After incubation at 37°C for 3 min, the reaction was stopped by adding 0.5 ml of 4 M ice-cold perchloric acid (PCA). After centrifugation at 13,000 g for 10 min, the pellet was washed with 500 µl of 2 mM PCA, resuspended in 800 µl of water, and extracted with 600 µl of butanol. Three hundred microliters of butanol phase was counted by liquid scintillation.
Fatty acid oxidation
Fatty acid oxidation was measured as described by Mannaerts et al. (30) with minor modifications. BAT was homogenized in Krebs-Henseleit bicarbonate buffer and centrifuged at 800 g for 10 min. The resultant supernatant was used for the assay. The reaction mixture contained 0.2 mM [14C]palmitic acid, 4 mM ATP, 50 µmol of CoA, 0.5 mM L-carnitine, 2 mM DTT, and 7.2 mg/ml albumin with or without 2 mM KCN in 2 ml. The reaction was started by adding the substrate and incubating the preparation at 37°C for 10 min. The reaction was terminated by adding 1 ml of 6% PCA, followed by centrifugation. The supernatant was extracted three times with 1 ml of petroleum ether to remove residual radiolabeled palmitate. The radioactivity of the aqueous phase was measured.
Protein content
The protein concentration was determined with the Bio-Rad protein assay (Hercules, CA) using BSA as a standard.
Lipid analysis
Total lipids were extracted from BAT according to the method of Bligh and Dyer (31). For analysis of TG, 1,2-diacylglycerol (DAG), FFAs, and phospholipids (PLs), BAT was homogenized and the lipids were extracted with 3 ml of chloroform-methanol (2:1). After centrifugation, the organic phase was collected and dried under nitrogen and then dissolved in 100 µl of hexane. The extracts were separated by TLC using hexane-diethylether-acetic acid (80:20:1) as a solvent system. The bands were scraped from the plates, methylated, and analyzed by gas-liquid chromatography as previously described (7).
Primary culture of brown adipocytes and in vitro lipolysis
BAT precursor cells were isolated from interscapular brown fat depots from SCD1+/+ and SCD1/ mice, as described (32). Briefly, BAT was minced in HEPES-buffered Ringer solution containing 0.2% (w/v) collagenase type II (Sigma) and digested for 30 min at 37°C. The brown adipocytes were grown at 37°C in an atmosphere of 5% CO2 in air, and the culture medium consisted of DMEM supplemented with 10% newborn calf serum, 4 nM insulin, 25 µg/ml sodium ascorbate, 10 mM HEPES, 4 mM glutamine, 50 U/ml penicillin, and 50 µg/ml streptomycin. After 10 days, brown adipocytes were incubated in Krebs buffer containing 10 µM T3 for 10 min, and medium was collected, deproteinated with 31% PCA, and neutralized with 5 M K2CO3. After centrifugation for 10 min at 3,000 g, the supernatant was used to determine glycerol using a commercially available enzymatic kit (Roche Molecular Biochemicals, Indianapolis, IN).
Analytical procedures
Plasma glucose was analyzed using a colorimetric method (Sigma), and glycogen content was measured as described (33).
Statistical analysis
Statistical analysis was performed with Student's unpaired t-test, with statistical significance set at P < 0.05.
| RESULTS |
|---|
|
|
|---|
|
|
, a coactivator of nuclear receptors implicated in adaptive thermogenesis and mitochondrial biogenesis. The PGC1
effects are mediated through the ß3-adrenergic pathway (36, 37). To determine whether PGC1
is responsible for increased UCP1 expression, we measured PGC1
mRNA and protein levels in BAT of SCD1/ and SCD1+/+ mice. The PGC1
protein level was increased by 1.9-fold in SCD1/ mice relative to SCD1+/+ mice (Fig. 2B). However, the PGC1
mRNA level was not affected by SCD1 deficiency (data not shown).
SCD1 deficiency increases lipolysis and fatty acid oxidation in BAT
Because activated ß3-AR induces lipolysis in adipose tissue and lipolysis is believed to be closely connected to the activation of UCP1 in BAT, we measured HSL expression to determine whether upregulation of UCPs results from increased lipolysis in BAT of SCD1/ mice. The HSL mRNA level was increased by 2.4-fold in BAT of SCD1/ mice relative to wild-type mice (Fig. 3A)
. In vitro experiments showed that T3-induced glycerol release increased by 1.8-fold in cultured brown adipocytes isolated from SCD1/ mice relative to those from SCD1+/+ mice (Fig. 3B).
|
|
|
|
|
|
In a cold environment, de novo lipogenesis enhances cold acclimation by increasing lipid utilization and heat production (38, 39). To determine whether cold exposure changes fat stores in plasma, BAT, and liver, the amount of TG was analyzed. As shown in Table 1, plasma TG content is lower in SCD1/ relative to SCD1+/+ mice at 22°C. Cold exposure further decreased plasma TG content in SCD1+/+ and SCD1/ mice by 30% and 44%, respectively. Plasma FFA content was also decreased in SCD1/ mice relative to SCD1+/+ mice at 22°C. Cold exposure decreased plasma FFA content in SCD1+/+ mice by 13%. However, plasma FFA content was increased by 1.5-fold in SCD1/ mice. BAT and liver TG content was decreased in SCD1/ mice relative to SCD1+/+ mice at 22°C. Upon cold exposure, BAT and liver TG content was increased by 1.5- and 1.6-fold, respectively, in SCD1+/+ mice. However, TG content was not changed in the BAT and liver of SCD1/ mice.
Dietary oleate partially rescues the hypothermia induced by hypoglycemia in cold-exposed SCD1/ mice
Because oleate is the primary product of SCD1 gene expression and is synthesized either de novo or by desaturation of exogenous stearate from the diet, we investigated whether dietary supplementation of triolein to the mice for 3 weeks would reverse the hypothermia observed in cold-exposed SCD1/ mice. Tristearin was used as a control for the triolein effect. SCD1/ mice fed the tristearin diet decreased body temperature quickly relative to SCD1+/+ mice (Fig. 7A)
. However, SCD1/ mice fed the triolein-supplemented diet showed higher body temperature at 3 and 4 h after cold exposure relative to SCD1/ mice fed the tristearin diet, although the body temperature continued to decrease. Dietary triolein or tristearin did not influence body temperature in SCD1+/+ mice during cold exposure. To determine whether triolein feeding influenced UCP1 expression, we analyzed UCP1 mRNA levels in BAT of SCD1+/+ and SCD1/ mice. UCP1 mRNA levels were not changed in either SCD1+/+ or SCD1/ mice upon triolein supplementation (Fig. 7B). To determine whether partial recovery of body temperature by triolein supplementation is associated with glycogen metabolism, plasma glucose and liver glycogen levels were measured. Dietary triolein increased plasma glucose (Fig. 7C) and liver glycogen (Fig. 7D) in SCD1/ mice by 1.9- and 2.2-fold, respectively, but did not rescue plasma glucose and liver glycogen to the levels found in SCD1+/+ mice. TG content was also measured to determine whether dietary triolein influences fat accumulation in BAT and liver. As shown in Table 3, long-term feeding of high levels of dietary triolein increased the TG content of BAT and liver of SCD1+/+ and SCD1/ mice. The TG levels in liver and BAT of SCD1/ were not increased to the levels found in SCD1+/+ mice.
|
|
| DISCUSSION |
|---|
|
|
|---|
The mechanism of increased UCP1 expression in BAT of SCD1/ mice is currently unknown. The results presented here suggest that it may involve the activation of the ß3-AR-specific signaling pathway. Figure 2 shows that ß3-AR mRNA and protein expression were increased in SCD1/ mice. The increase in ß3-AR expression was accompanied by increased activation of pCREB, which is the primary downstream factor of ß3-AR-mediated pathways in BAT. Phosphorylation on the serine-133 residue of CREB in response to noradrenergic activation activates the transcription of the UCP1 gene (34, 35). Increased levels of PGC1
protein in BAT also support the activation of UCP1 expression in SCD1/ mice because PGC1
strongly coactivates several nuclear receptors (peroxisome proliferator-activated receptor
, peroxisome proliferator-activated receptor
, retinoic acid receptor, and thyroid hormone receptor) that bind to the UCP1 enhancer, and recent reports indicate that a major portion of the cAMP effect is mediated by PGC1
(36, 37). The CREB and PGC1
mRNA levels were not different between SCD1+/+ and SCD1/ mice, suggesting that SCD1 deficiency induces the activation of CREB by increasing its phosphorylation and regulates PGC1
expression at a posttranscriptional level.
The increased expression of HSL (Fig. 3A) and the reduction in levels of TG and 1,2-DAG content (Fig. 4A, B) suggest increased lipolysis in BAT of SCD1/ mice. The plasma fatty acid levels would be expected to increase. However, the content of FFA fraction in BAT (Fig. 4C) and in the plasma (Table 1) was decreased in SCD1/ mice. The increased CPT1 gene expression and enzyme activity as well as the increased oxidation of palmitic acid (Fig. 5) provide evidence of the more efficient FFA oxidation in BAT of SCD1/ mice.
We hypothesized that SCD1 deficiency enhances cold-induced thermogenesis because SCD1 deficiency upregulates thermogenic activity in BAT at room temperature. Paradoxically, we found that SCD1/ mice showed very severe hypothermia after only 3 h of cold exposure. Moreover, UCP1 was not responsible for cold-induced hypothermia in SCD1/ mice. Survival in the cold depends on increased energy expenditure and thus requires sustained substrate mobilization from the main energy stores, liver glycogen and adipose tissue. We found that SCD1/ mice had reduced levels of liver glycogen, which suggests that SCD1/ mice use glycogen more efficiently than SCD1+/+ mice for thermogenesis. The muscle and BAT glycogen content was not significantly decreased in SCD1/ mice upon cold exposure (data not shown). This observation suggests that liver glycogen plays a role in whole-body metabolism and serves to maintain a constant level of glucose in the blood while glycogen of the peripheral tissues is used for local energy demand. On the other hand, increase in lipid utilization during cold exposure is a strategy to spare limited carbohydrate reserves. An increase in the use of lipids allows the maintenance of heat production for a longer period and therefore improves chances of survival in the cold (40). Actually, cold induces a large increase of de novo lipogenesis in thermogenic tissue such as BAT and liver after cold exposure, suggesting that lipogenesis is an essential step of cold acclimation (38, 39). We found a decrease in hepatic TG content and an increase in plasma FFA level in SCD1/ mice after cold exposure.
The reduced lipogenesis and reduced lipid utilization in SCD1/ mice could be responsible for the reduced heat production in the absence of carbohydrate sources. Therefore, we tested the possibility that dietary oleate would help in maintaining body temperature by increasing TG synthesis in SCD1/ mice during cold exposure. Our results showed that high levels of dietary oleate partially rescued the deficiency of glycogen and TG in liver of SCD1/ mice (Fig. 7). Dietary stearate or palmitate did not rescue the glycogen or TG deficiency in the livers of SCD1/ mice (data not shown). These results support the hypothesis that glycogen and TG levels in liver of SCD1/ mice might be affected by the presence of endogenously synthesized oleate, consistent with previous results (7). We do not exclude the possibility that cold injury may occur in the plasma membrane of SCD1/ mice after cold exposure because SCD1/ mice fed tristearin exhibited very severe cold sensitivity and died after 2 h of cold exposure. An altered lipid profile (low ratio of MUFA to saturated fatty acids) may change membrane fluidity and induce lipid-phase transition (41).
In conclusion, our study provides information on the role of SCD1 deficiency in stimulating the metabolic rate and the molecular events of basal thermogenesis. As depicted in Fig. 8
, lack of the SCD1 gene coordinates the signal leading from ß3-AR activation to phosphorylation of CREB and activation of PGC1
, which mediate the activation of UCP1. The resulting increase in lipolysis in SCD1/ mice might provide the substrate for mitochondrial oxidation and induce the simultaneous stimulation of UCP1 expression and basal thermogenesis. These phenomena together result in increased energy expenditure and reduction in adiposity. However, SCD1 deficiency induced hypothermia, which is associated with hypoglycemia after cold exposure. The hypothermia and hypoglycemia in cold-exposed SCD1/ mice and the compensatory recovery by dietary oleate suggest a significant role of SCD1 gene expression in thermoregulation, which is associated with glycogen and lipid metabolism.
|
| ACKNOWLEDGMENTS |
|---|
Manuscript received January 30, 2004 and in revised form May 17, 2004.
| REFERENCES |
|---|
|
|
|---|
coactivator 1
(PGC1
): transcriptional coactivator and metabolic regulator. Endocr. Rev. 24: 7890.This article has been cited by other articles:
![]() |
P. Dobrzyn, H. Sampath, A. Dobrzyn, M. Miyazaki, and J. M. Ntambi Loss of stearoyl-CoA desaturase 1 inhibits fatty acid oxidation and increases glucose utilization in the heart Am J Physiol Endocrinol Metab, February 1, 2008; 294(2): E357 - E364. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. J. Brock, J. Browse, and J. L. Watts Fatty Acid Desaturation and the Regulation of Adiposity in Caenorhabditis elegans Genetics, June 1, 2007; 176(2): 865 - 875. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Dobrzyn, P. Dobrzyn, S.-H. Lee, M. Miyazaki, P. Cohen, E. Asilmaz, D. G. Hardie, J. M. Friedman, and J. M. Ntambi Stearoyl-CoA desaturase-1 deficiency reduces ceramide synthesis by downregulating serine palmitoyltransferase and increasing {beta}-oxidation in skeletal muscle Am J Physiol Endocrinol Metab, March 1, 2005; 288(3): E599 - E607. [Abstract] [Full Text] [PDF] |
||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||